Zobrazeno 1 - 10
of 93
pro vyhledávání: '"Shelly R. Peyton"'
Publikováno v:
BME Frontiers, Vol 4 (2023)
We need novel strategies to target the complexity of cancer and, particularly, of metastatic disease. As an example of this complexity, certain tissues are particularly hospitable environments for metastases, whereas others do not contain fertile mic
Externí odkaz:
https://doaj.org/article/ede2b7ab21dd4589900c6c096668c983
Publikováno v:
Bioengineering & Translational Medicine, Vol 5, Iss 1, Pp n/a-n/a (2020)
Abstract Cell motility is a critical aspect of several processes, such as wound healing and immunity; however, it is dysregulated in cancer. Current limitations of imaging tools make it difficult to study cell migration in vivo. To overcome this, and
Externí odkaz:
https://doaj.org/article/14719e1c73cd472698ef8af654294217
Autor:
Constance C. Angelou, Alexandria C. Wells, Jyothi Vijayaraghavan, Carey E. Dougan, Rebecca Lawlor, Elizabeth Iverson, Vanja Lazarevic, Motoko Y. Kimura, Shelly R. Peyton, Lisa M. Minter, Barbara A. Osborne, Elena L. Pobezinskaya, Leonid A. Pobezinsky
Publikováno v:
Frontiers in Immunology, Vol 10 (2020)
Multiple sclerosis (MS) is a disabling demyelinating autoimmune disorder of the central nervous system (CNS) which is driven by IL-23- and IL-1β-induced autoreactive Th17 cells that traffic to the CNS and secrete proinflammatory cytokines. Th17 path
Externí odkaz:
https://doaj.org/article/a7dd3d5c2ffa4be3b33d686e3be2cc19
Autor:
Elizabeth A. Brooks, Maria F. Gencoglu, Daniel C. Corbett, Kelly R. Stevens, Shelly R. Peyton
Publikováno v:
APL Bioengineering, Vol 3, Iss 2, Pp 026106-026106-10 (2019)
Ovarian cancer (OvCa) is a challenging disease to treat due to poor screening techniques and late diagnosis. There is an urgent need for additional therapy options, as patients recur in 70% of cases. The limited availability of clinical treatment opt
Externí odkaz:
https://doaj.org/article/4fad05bb0fe64432b92af52eba1f60ca
Autor:
Igor D. Luzhansky, Alyssa D. Schwartz, Joshua D. Cohen, John P. MacMunn, Lauren E. Barney, Lauren E. Jansen, Shelly R. Peyton
Publikováno v:
APL Bioengineering, Vol 2, Iss 2, Pp 026112-026112-15 (2018)
Appropriately chosen descriptive models of cell migration in biomaterials will allow researchers to characterize and ultimately predict the movement of cells in engineered systems for a variety of applications in tissue engineering. The persistent ra
Externí odkaz:
https://doaj.org/article/fa809ec083db42f497ec3735694a3d27
Autor:
K. P. Sonu, Le Zhou, Santidan Biswas, John Klier, Anna C. Balazs, Todd Emrick, Shelly R. Peyton
Publikováno v:
Langmuir. 39:2659-2666
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e87c923c5f5ed20d94049388357fd295
https://doi.org/10.1021/acs.langmuir.2c03117
https://doi.org/10.1021/acs.langmuir.2c03117
Autor:
Aritra Nath Kundu, Carey E. Dougan, Samar Mahmoud, Alara Kilic, Alexi Panagiotou, Nathan Richbourg, Ninette Irakoze, Shelly R. Peyton
Publikováno v:
Advanced Materials.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f6029719644cbf98a25b4174328f06ed
https://doi.org/10.1002/adma.202301493
https://doi.org/10.1002/adma.202301493
Publikováno v:
Soft Matter
Metastatic cancer has a poor prognosis, because it is broadly disseminated and associated with both intrinsic and acquired drug resistance. Critical unmet needs in effectively killing drug resistant cancer cells include overcoming the drug desensitiz
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8212939cb41444a0ffb41effcb03c93c
https://doi.org/10.1039/d2sm00071g
https://doi.org/10.1039/d2sm00071g
Breast cancer is a leading cause of global cancer-related deaths, and metastasis is the overwhelming culprit of poor patient prognosis. The most nefarious aspect of metastasis is dormancy, a prolonged period between primary tumor resection and relaps
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::61087bdce6973298a0fff9a65bcfe4d2
https://doi.org/10.1101/2022.10.08.511405
https://doi.org/10.1101/2022.10.08.511405
Autor:
Elizabeth Cosgriff-Hernandez, Brian A. Aguado, Belinda Sena Akpa, Gabriella Coloyan Fleming, Erika Moore, Ana Maria Porras, Patrick M. Boyle, Deva D. Chan, Naomi Chesler, Karen L. Christman, Tejal A. Desai, Brendan A.C. Harley, Megan L. Killian, Katharina Maisel, Kristen C. Maitland, Shelly R. Peyton, Beth L. Pruitt, Sarah E. Stabenfeldt, Kelly R. Stevens, Audrey Bowden
Hiring practices in academia have critically limited the entry of individuals from historically excluded groups into our biomedical engineering faculty. Excluding diverse individuals has hindered our profession’s research impact and ability to equi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::75c65063e9528eb0c628766ae26d1a04
https://doi.org/10.35542/osf.io/8hcw5
https://doi.org/10.35542/osf.io/8hcw5